Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

COVID-19 may cause hair loss by affecting hair follicles.

Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.

A new microneedle treatment shows promise for better hair regrowth in androgenetic alopecia.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

Dermoscopy is a useful, low-cost method for diagnosing various types of hair loss disorders known as Cicatricial Alopecia.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Dandruff might be caused by changes in how hair follicles naturally release oils and an immune response to this imbalance.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Botulinum toxin shows promise for treating scalp sweating but not for hair growth.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Sebum is essential for skin health but can cause acne if unbalanced.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

New treatments for alopecia areata focus on targeting immune responses for better results.

Using combined fat and growth factors can effectively treat hair loss after facial fillers.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

Acne treatment with isotretinoin increases the presence of p53, a protein, in skin and oil glands, which may help reduce acne severity.

Improving understanding of laser hair removal can reduce anxiety and help people make better decisions.

Stem cell and plant exosomes may help heal and regenerate skin.